Pascal Geldsetzer

Pascal Geldsetzer

researcher United States

Pascal Geldsetzer is a researcher at Stanford University who focuses on healthcare policy and epidemiology. His recent work has provided strong evidence that the shingles vaccine, Zostavax, significantly reduces the risk of developing dementia. This groundbreaking study utilized health records from over 280,000 older adults in Wales, marking a pivotal advancement in understanding the potential protective effects of vaccinations on brain health.

Global Media Ratings
Dominance
0.01%
Persistence
0 wks
Reach
158,319
Power
10,099$
Sentiment
8.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
United States 1 8.00 0.05% +0% 331,002,651 153,313 $21,000,000 9,727$
Norway 1 8.00 0.09% +0% 5,421,241 5,006 $403,000 372$
Totals 2 336,423,892 158,319 $21,403,000 10,099$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Norway Norway: Pascal Geldsetzer from Stanford University emphasizes the importance of the findings regarding the shingles vaccine and dementia risk. 8

Aftenposten: Voldsom interesse for vaksine som gir lavere risiko for demens

United States United States: Dr. Pascal Geldsetzer, assistant professor of medicine and senior author of the new study, told Fox News Digital. 8

Fox News: Shingles vaccine may slow dementia progression in existing patients

Romania Romania: Pascal Geldsetzer is an assistant professor of medicine at Stanford University School of Medicine and the lead author of a study on vaccines and dementia. 8

Adevărul: Patru vaccinuri ce protejează împotriva unor boli ar putea scădea riscul de demență

Liechtenstein Liechtenstein: Pascal Geldsetzer is a professor of medicine at Stanford University and the lead author of a study on vaccines and dementia risk. 8

O Estado de S. Paulo (Estadão): 4 vacinas são associadas a um menor risco de demência

New Zealand New Zealand: Pascal Geldsetzer is an assistant professor of medicine at Stanford University School of Medicine and senior author of the study. 8

The New Zealand Herald – country’s largest newspaper, est. 1863: I’m a brain health expert - here’s why shingles vaccines may fight dementia

France France: Pascal Geldsetzer is a doctor at Stanford and the lead author of the study. 8

Le Monde: Un vaccin contre le zona réduirait de 20 % le risque de démence, selon une étude américaine

United States United States: Senior study author Pascal Geldsetzer, MD, PhD, assistant professor of medicine at Stanford, said he considers these findings 'hugely important' for clinical medicine, population health and research. 8

Fox News: Research shows link between shingles vaccine and lower dementia risk

Portugal Portugal: Pascal Geldsetzer from Stanford University emphasized the significance of the findings regarding the shingles vaccine and dementia risk. 8

Público: Vacina da zona pode diminuir risco de demência | Saúde

Taiwan Taiwan: Pascal Geldsetzer is the lead researcher of the study published in Nature regarding shingles vaccinations and dementia. 9

Taipei Times – major English newspaper in Taiwan, est. 1999: Shingles vaccinations may fight dementia